Company news
Adhera Therapeutics Inc. news in 2014
Adhera Therapeutics Inc.'s news releases, calls and decks from 2014, newest first.
Marina Biotech and MiNA Therapeutics Announce License Agreement for the Development of saRNA-Based Therapeutics
December 18, 2014
Marina Biotech Reports That Licensee ProNAi Therapeutics Presented Interim Phase 2 Data on Its BCL2-Targeting DNAi(R) Therapeutic at ASH 2014
December 9, 2014
Marina Biotech Reports That Partner Mirna Therapeutics Presented Interim Phase 1 Data on Its First-in-Class microRNA-34 Mimic
November 20, 2014
Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance
November 18, 2014
Marina Biotech Announces Third Quarter 2014 Financial Results
November 17, 2014
Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors
September 16, 2014
Marina Biotech Announces the Continued Worldwide Expansion of Its Delivery Technology Intellectual Property Estate
September 11, 2014
Decks in 2014
- Marina Biotech — Nucleic Acid Therapeutics and Rare Diseases Annual Meeting (September 2014)
Conference · 32 slides · Sep 19, 2014
- Marina Biotech — BIO-Europe Spring 2014
Conference · 25 slides · Mar 11, 2014